top of page

Clinical Evaluation and Literature Review: Before ÜTS Registration

Literature review and clinical evaluation report for Class I and IIa devices; a technical file ready for ÜTS document registration.

Clinical Evaluation and Literature Review: Before ÜTS Registration

Medical Device Clinical Evaluation and Literature Review Service

For Class I and Class IIa medical devices, we carry out a systematic literature review, compile data on equivalent or similar devices, and prepare or update the clinical evaluation report from the data you hold. The report is a section of your technical file and shows the clinical evidence on which your declaration of conformity rests. To start, send the intended purpose, the device description and, if you have one, the existing report. Request a quote.

Who it is for

  • Class I device manufacturers who draw up their own declaration of conformity and must show the clinical evaluation in the technical file.
  • Class IIa device manufacturers who want to refresh their report with current literature before the notified body review.
  • Domestic manufacturers who want a report prepared in the Directive era rewritten according to the Medical Device Regulation.
  • Companies whose clinical evaluation turns out to be incomplete in a technical file pre-review.

We do not provide this service for Class IIb, Class III and implantable devices. These devices require clinical investigation and a clinical development process with a notified body; a desk-based literature study alone is not enough.

Legal basis

The basis and the responsible party for clinical evaluation are written in the Medical Device Regulation:

“Confirmation of conformity with relevant general safety and performance requirements set out in Annex I under the normal conditions of the intended use of the device, and the evaluation of the undesirable side-effects and of the acceptability of the benefit-risk ratio referred to in Sections 1 and 8 of Annex I, shall be based on clinical data providing sufficient clinical evidence, including where applicable relevant data as referred to in Annex III. The manufacturer shall specify and justify the level of clinical evidence necessary to demonstrate conformity with the relevant general safety and performance requirements. That level of clinical evidence shall be appropriate in view of the characteristics of the device and its intended purpose. To that end, manufacturers shall plan, conduct and document a clinical evaluation in accordance with this Article and Part A of Annex XIV.” (Medical Device Regulation Art. 61/1)

A literature review is one of the mandatory steps of clinical evaluation:

“Identify available clinical data relevant to the device and its intended purpose and any gaps in clinical evidence through a systematic scientific literature review,” (Medical Device Regulation Annex XIV Part A 1-b)

The result is collected in a report:

“The clinical evaluation and its outcome shall be documented in a clinical evaluation report which shall support the assessment of the conformity of the device.” (Medical Device Regulation Annex XIV Part A 4)

For implantable devices and Class III devices the rule is different, which is why we keep these devices out of scope:

“In the case of implantable devices and class III devices, clinical investigations shall be performed, except if all of the following conditions are met:” (Medical Device Regulation Art. 61/4-a)

What we do

  • Clinical evaluation plan: according to the headings in Annex XIV Part A 1-a: the general safety and performance requirements to be supported by clinical data, intended purpose, target group, indications and contraindications, clinical benefits and benefit-risk parameters.
  • Systematic literature review: the search strategy, the databases used, keywords, inclusion and exclusion criteria and an appraisal record for each article. The review is written in a repeatable way.
  • Equivalent or similar device data: a comparison table according to the technical, biological and clinical characteristics in Annex XIV Part A 3. If you do not have access to the data needed for an equivalence claim, we state this clearly in the report; we do not construct an equivalence that does not exist.
  • The state of the art: a summary of the alternative treatments and devices used for the same clinical purpose.
  • Clinical evaluation report: a draft report in which favourable and unfavourable data are evaluated together, showing the conclusion and the remaining gaps.
  • Update: we rewrite your existing report with new literature, post-market surveillance data and complaint records.

The report is prepared with the structure of the MEDDEV 2.7/1 rev.4 guidance and the MDCG 2020-6 guidance in mind. We explain what clinical evaluation is and what it proves on our clinical evaluation glossary page.

How the literature review runs

The review is recorded in such a way that someone else can repeat the result later.

  • Question definition: which device, which patient group, which clinical purpose and which outcome parameters.
  • Databases and sources: scientific publication databases, clinical investigation registers and adverse event records.
  • Search terms: the words used, synonyms and filters are written with their dates.
  • Screening: first title and abstract, then full text; the reason for each excluded source is recorded.
  • Appraisal: the suitability of each source to the device and its contribution to the clinical evidence are scored separately.
  • Data extraction: safety and performance results are collected in a single table.

As required by Annex XIV Part A 2, clinical evaluation takes favourable and unfavourable data into account together. We do not leave out publications that report unfavourable results; we write in the report how they were handled.

What we check in an existing report

If you want us to update your report, we first identify its gaps:

  • Is there a clinical evaluation plan, and does it meet the headings in Annex XIV Part A 1-a?
  • Are the intended purpose, indications and target patient group the same as in the label, instructions for use and declaration of conformity?
  • Is the literature review repeatable, and is the search date current?
  • Is the equivalence claim shown with technical, biological and clinical characteristics, and is access to the data documented?
  • Do the residual risks in the risk management file find a counterpart in the report?
  • Does the conclusion section give a clear verdict on the benefit-risk ratio?
  • Have post-market surveillance and complaint data been incorporated into the report?

Which devices it is suitable for

Class I devices such as orthoses, wheelchairs, examination gloves, spectacle frames and reusable surgical hand instruments, and non-implantable Class IIa devices. If you are not sure of your device’s class, we start by checking the applied classification rule together.

Who signs the report

Planning, conducting and documenting the clinical evaluation is the manufacturer’s obligation under Art. 61/1. We prepare the report; the manufacturer decides whether the level of clinical evidence is sufficient, and the report is approved by the manufacturer’s evaluator. We do not write medical opinions and we do not provide a physician’s signature. The manufacturer determines who the evaluator will be and what their qualifications are.

Link to post-market clinical follow-up

Clinical evaluation is not written once and left. Post-market clinical follow-up is defined in Annex XIV Part B as a continuous process that updates the clinical evaluation. Art. 61/10 of the Medical Device Regulation requires the clinical evaluation and its documentation to be updated throughout the life cycle of the device with clinical data from the post-market clinical follow-up and post-market surveillance plans. For this reason, in the report we also list separately the open points to be addressed in the follow-up plan. A new variant, a new indication, a new patient group or a new risk seen in complaint records is also a reason to update the report; in an update we rewrite not only the changed sections but also the conclusion. For details, see our post on clinical evaluation and PMCF and our PMCF glossary page.

Process

The work is carried out by correspondence and online meetings; at every step we write in advance what we expect from you and what we will deliver to you. Drafts come as editable files so that your evaluator can write notes directly on the text.

  • You send the intended purpose, device description, risk class, risk management file and, if any, the existing clinical evaluation report.
  • We prepare the clinical evaluation plan and the literature search strategy and submit them for your approval.
  • We carry out the review, appraise the articles and build the equivalence or similar device table.
  • We send the draft clinical evaluation report; we incorporate your questions and your evaluator’s notes.
  • We deliver the final version in a form that can be added to the technical file.

What we deliver

  • Clinical evaluation plan.
  • Literature search protocol and search record: databases, search terms, included and excluded sources.
  • Article appraisal table.
  • Equivalence or similar device comparison table, if applicable.
  • Clinical evaluation report, in Turkish or English.
  • A list of gaps in the clinical evidence and of points to be addressed in post-market clinical follow-up.

What we ask from you

  • Intended purpose, indications, contraindications and target patient group.
  • Device description, variants, materials and working principle.
  • Risk class and the classification rule applied.
  • Risk management file.
  • Instructions for use and label.
  • If any, the existing clinical evaluation report, post-market surveillance data and complaint records.
  • If equivalence is to be claimed, documents showing your access to the technical data of the equivalent device.

Out of scope

  • Notified body conformity assessment and CE certification.
  • Test and laboratory processes, including laboratory selection and arranging tests.
  • Interpreting or changing your technical specifications.
  • Finding an importer or distributor.

In addition, we do not conduct clinical investigations, act as a legal representative for clinical investigations, collect patient data or give medical opinions.

Related services

Frequently asked questions

Is a clinical evaluation needed for a Class I device?

Yes. Art. 61/1 makes no distinction; the manufacturer plans, conducts and documents a clinical evaluation for every device. The depth is proportionate to the nature, class and risks of the device.

Can there be a clinical evaluation without a clinical investigation?

Art. 61/3-a provides that the clinical evaluation may be based on a critical evaluation of the relevant scientific literature of the device for which equivalence is demonstrated. For implantable and Class III devices, however, a clinical investigation is in principle required under Art. 61/4-a.

Can I use equivalent device data?

If the technical, biological and clinical characteristics in Annex XIV Part A 3 can be demonstrated and you have sufficient access to the equivalent device’s data. If access cannot be demonstrated, equivalence is not claimed; we state this clearly in the report.

Do you sign the report?

No. We prepare the report; the manufacturer decides on its sufficiency and its own evaluator approves it.

Is my report prepared in the Directive era still valid?

For a device under the Medical Device Regulation, the report must comply with Art. 61 and Annex XIV Part A. We take the existing report as a basis, complete the missing headings and update the literature.

Where is the report kept?

Under Annex XIV Part A 4, the clinical evaluation report is a part of the technical file and is kept by the manufacturer together with the technical file.

In which language is the report prepared?

In Turkish or English, according to your need.

To get started, you can request a quote for ÜTS registration consultancy.

Medical Device ÜTS Registration Consultancy

Request an ÜTS registration consultancy quote

Ehlibeyt Mahallesi, Tekstilciler Caddesi No: 35/7 06520 Çankaya / Ankara - TÜRKİYE

Cevizli Mahallesi, Zuhal Caddesi Ritim İstanbul B Blok, No:44 Maltepe / İstanbul - TÜRKİYE

info@medexmedikal.com
+90 505 580 4622
+90 312 389 1354

ÜTS Guides · Legislation Calendar · Glossary · ÜTS Guide Index · Frequently Asked Questions

Services: ÜTS Consultancy · Who Carries Out the ÜTS Registration? · ÜTS Document Registration Consultancy · ÜTS Product Registration Consultancy · Importer ÜTS Registration Consultancy · Sales Centre Authorisation Certificate · EUDAMED Registration Consultancy · MDR/IVDR Declaration of Conformity · Technical File Preliminary Review · Label and Instructions for Use Check · PRRC Service · PMS and PSUR · Clinical Evaluation · EMDN and GMDN Code Determination · Certificate of Free Sale · EUDAMED XML Generator · ÜTS Registration Training · Correction of a Rejected ÜTS Application

KVKK and Privacy Policy | Cookie Policy | Accessibility Statement

© 2026 Medex Kurumsal Danışmanlık Ltd. Şti.

bottom of page
WhatsApp Hemen Ara